Peter Goulden, MD, an endocrinologist at Mount Sinai, told Vogue that compounded GLP-1s may carry risks due to lack of standardized dosing or full clinical oversight. Similarly, Dr
This review focuses on the development of different amino acid depletion treatments in treating cancer
And some are trying to stretch or reshape a supply
FDA Compounding Policies Impacting Tirzepatide in 2026 The FDA has made its rules on drug compounding clear, with more focus on GLP-1 rules now that there is enough supply
We explored how the industry is developing next-gen, sustainable, plant-based active nutrition with Bioiberica, Cosun Protein, Gnosis by Lesaffre, HTBA, Lactalis Ingredients, Sensus, and Sirio Europe